26th Annual EuroMeeting Vienna 2014

The DIA Annual EuroMeeting is global in scope and attracts well over 3,000 professionals from more than 50 countries. It brings together professionals from the biopharmaceutical industry, contract research organisations, academic research centres, regulatory agencies and health ministries as well as delegates from patient organisations.

Attendees will have access to more than 100 sessions in 16 parallel themes and the chance to hear from 350+ expert speakers, including representatives from the European Medicines Agency (EMA), the European Commission, the Food and Drug Administration (FDA), and regulatory agencies from around the world. Participants can also find out about the latest innovations in their field by touring the exhibition hall featuring 170 companies, and view the latest research on display through student and professional posters.

EuroMeeting 2014 Co-chair Angelika Joos, Head of Regulatory Policy for EU and Most of World at Merck Sharp and Dohme in Belgium, says Vienna is in the centre of Europe – ideal for building bridges between East and West, North and South. The EuroMeeting 2014 will be the meeting point and melting pot for all involved in making available the health products of the future.

The conference will facilitate debate on key issues in the life sciences industry, from how to involve and inform patients and citizens in the whole lifecycle of health products, to the opportunities and challenges of bringing personalised medicines to market. Other hot topics for discussion include the proposal for the Clinical Trials Directive, initiatives on Health Technology Assessment (HTA), the start of implementation of the Directive of Falsified Medicines, and how the Horizon 2020 research programme will contribute to innovation and the availability of medicines and treatments.